Top Markets
Coin of the day
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
Rangering i aksjer #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
Aksjekurs
$1.05
Sist synkronisert: 2026-08-19
Markedsverdi
$25.12M
Endring (1 dag)
0.00%
Endring (1 år)
-86.33%
Land
US
Handel Actuate Therapeutics Inc (ACTU)

Kategori

Historikk for aksjesplitt for Actuate Therapeutics Inc (ACTU)
Aksjen Actuate Therapeutics Inc (symbol: ACTU) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 20, 2026.
Én ACTU-aksje kjøpt før Aug 20, 2026 tilsvarer i dag 0 ACTU-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH